Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production

ASAIO Journal

Volumn 44, Issue 5, 1998, Pages

  Panichi, Vincenzo ^e   Tetta, Ciro ^a   Rindi, Paolo ^b   Palla, Roberto ^c   Lonnemann, Gerhard ^d  

^a Cyberonics Inc   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Civil Hospital   (Italy)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

FILTRATION; PATIENT TREATMENT; PROTEINS;

BACKFILTRATION; HEMODIALYSIS; INTERLEUKIN;

DIALYSIS;

C REACTIVE PROTEIN; INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BACTERIUM CONTAMINATION; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIALYSATE; FILTRATION; HEMOFILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTICENTER STUDY; PROTEIN BINDING;

EID: 0032170438     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199809000-00018     Document Type: Article

References (26)

1. Harding GB, Klein E, Pass T, et al: Endotoxin and bacterial contamination of dialysis center water and dialysate: a cross sectional survey. Int J Artif Organs 13: 39-43, 1990.
2. Bambauer R, Walther J, Meyer S, et al: Bacteria-and endotoxin-free dialysis fluid for use in chronic hemodialysis. Artif Organs 18: 188-192, 1994.
3. Bland LA, Favero MS. Microbiologic Aspects of Hemodialysis Systems. Arlington, VA, Association for the Advancement of Medical Instruments, 1993, pp. 257-265.
4. Gordon SM, Oetlinger CW, Bland LA, et al: Pyrogenic reactions in patients receiving conventional high-efficiency or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 2: 1436-1444, 1992.
5. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of hemodialysis associated diseases in the United States. ASAIO J 39: 71-80, 1990.
6. Dinarello CA: Cytokines: agents provocateurs in hemodialysis. Kidney Int 41: 683-694, 1992.
7. Lonnemann G: Dialysate bacteriological quality and the permeability of dialyser membranes to pyrogens. Kidney Int 43(Suppl 41): S195-S200, 1993.
8. Pereira BJG: Cytokine production in patients on dialysis. Blood Purif 13: 135-146, 1995.
9. Pereira BJG, Snodgrass B, King AJ, Hogan P: Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 47: 603-610, 1995.
10. Evans RC, Holmes CJ: In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif 9: 92-101, 1991.
11. Lonnemann G, Koch KL: Replacement of renal function by dialysis, in Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds), Replacement of Renal Function by Dialysis. 4th ed. Dordrecht/Boston/London, Kluwer Academic Publishers, 1996, pp. 726-733.
12. Bommer J, Becker KP, Urbaschek R: Potential transfer of endotoxin across high-flux polysulfone membranes. J Am Soc Nephrol 7: 883-888, 1996.
13. Lonnemann G, Behme TC, Lenzner B, et al: Permeability of dialyser membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 42: 61-68, 1992.
14. Bambauer R, Walther J, Meyer S, et al: Bacteria-and endotoxin-free dialysis fluid for use in chronic hemodialysis. Artif Organs 18: 188-192, 1994.
15. Grooteman MPC, Nubé MJ, Daha MR, et al: Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes. J Am Soc Nephrol 8: 1745-1754, 1997.
16. Panichi V, De Pietro S, Andreini B, et al: Cytokine production in haemodiafiltration: a multicentre study. Nephrol Dial Transplant 13:1737-1744, 1998 (in press).
17. Ghezzi PM, Frigato G, Fantini GF, et al: Theoretical model and first clinical results of the paired filtration dialysis. Life Support Systems 1(Suppl 1): 271-278, 1983.
18. Ronco C, Feriani M, Brendolan S, et al: Paired filtration dialysis: studies on efficiency, flow dynamics and hydraulic properties of the system. Blood Purif 8: 126-140, 1990.
19. Kushner I: The acute phase reactants and the erythrocyte sedimentation rate, in Kelley WN, Harris ED, Ruddy S, Sledge CB (eds), The Textbook of Rheumatology. Philadelphia, WB Saunders, 1981, pp. 669-676.
20. Ridker PM, Cushman M, Stamfer MJ, et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997.
21. Liuzzo G, Biasucci LM: Prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417-423, 1994.
22. Maseri A: Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med 336: 1014, 1997.
23. Kaysen GA, Stevenson FT, Depner TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29: 658-668, 1997.
24. Barany P, Fiho JCD, Bergstrom J: High C-reactive protein is a stron predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29: 565-568, 1997.
25. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schultze M, Koch KM: Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Pent Dial Int 16: 158-162, 1996.
26. Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B: Inflammatory effects of peritoneal dialysate: evidence of systemic monocyte activation. Kidney Int 49: 506-511, 1996.